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Abstract: Objectives: Recovery of independent ambulation after stroke is a major goal. However, which
rehabilitation regimen best benefits each individual is unknown and decisions are currently made on a
subjective basis. Predictors of response to specific therapies would guide the type of therapy most
appropriate for each patient. Although lesion topography is a strong predictor of upper limb response,
walking involves more distributed functions. Earlier studies that assessed the cortico-spinal tract (CST)
were negative, suggesting other structures may be important. Experimental Design: The relationship
between lesion topography and response of walking speed to standard rehabilitation was assessed in
50 adult-onset patients using both volumetric measurement of CST lesion load and voxel-based lesion–
symptom mapping (VLSM) to assess non-CST structures. Two functional mobility scales, the functional
ambulation category (FAC) and the modified rivermead mobility index (MRMI) were also adminis-
tered. Performance measures were obtained both at entry into the study (3–42 days post-stroke) and at
the end of a 6-week course of therapy. Baseline score, age, time since stroke onset and white matter
hyperintensities score were included as nuisance covariates in regression models. Principal Observations:
CST damage independently predicted response to therapy for FAC and MRMI, but not for walk speed.
However, using VLSM the latter was predicted by damage to the putamen, insula, external capsule
and neighbouring white matter. Conclusions: Walk speed response to rehabilitation was affected by
damage involving the putamen and neighbouring structures but not the CST, while the latter had
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INTRODUCTION
Around a third of stroke survivors are unable to ambu-
late 6 months after stroke [Alexander et al., 2009], contrib-
uting a large portion of functional impairment and lost
independence. Accordingly, rehabilitation aimed at recov-
ering independent ambulation is an important part of
post-stroke therapy, using various techniques that include
apparatus-supported therapy such as treadmill exercise,
balance activities and orthoses. However, the type of ther-
apy that would best benefit each individual patient
remains uncertain, and currently post-stroke therapy deci-
sions are made on a subjective basis. Therefore, predictors
of response to therapy, that is, the gain in functional scores
between baseline and final assessments, would be of con-
siderable value in the clinical setting as they would point
to the type and amount of therapy most effective in each
individual. This would in turn maximize the effects of
therapy and enhance recovery for each particular lesion
type.
Although previous studies have disagreed regarding the
role of some clinical variables such as age, lesion volume
and white matter small vessel lesion load as predictors of
response to standard therapy [Burke et al., 2014; Cramer
et al., 2007; Dawes et al., 2008; Dobkin et al., 2014; Held
et al., 2012; Jorgensen et al., 1995; Kollen et al., 2005; Lam
et al., 2010; Lindenberg et al., 2012; O’Shea et al., 2014; Sti-
near et al., 2007], time since stroke onset has been consis-
tently found to influence, albeit weakly, response to
rehabilitation therapy [Kollen et al., 2005; Lam et al., 2010;
O’Shea et al., 2014; Stinear et al., 2007]. Another, probably
stronger clinical predictor is baseline impairment [Burke
et al., 2014; Cramer et al., 2007; Dawes et al., 2008; Dobkin
et al., 2014; Kollen et al., 2005; Lindenberg et al., 2012;
O’Shea et al., 2014; Riley et al., 2011; Stinear et al., 2007].
However, lesion topography is generally considered the
strongest potential predictor of response to therapy after
stroke.
Damage to the cortico-spinal tract (CST), and particu-
larly to the portion of the CST originating from the pri-
mary motor cortex (M1), has consistently been reported as
a major determinant of final outcome, including global
impairment [Pineiro et al., 2000; Puig et al., 2010, 2011,
2013] and particularly upper limb weakness [Feng et al., in
press; Kim et al., 2013; Lindenberg et al., 2010; Lo et al.,
2010; Maraka et al., 2014; Qiu et al., 2011; Rosso et al.,
2013; Schaechter et al., 2009; Schulz et al., 2012; Stinear
et al., 2007; Zhu et al., 2010]. However, information regard-
ing how lesion topography affects walking outcome is
scarce. As expected, based on established CST neuroanat-
omy, in three studies, leg weakness was significantly
related to CST damage measured as involvement of the
posterior limb of the internal capsule (PLIC) [Jayaram
et al., 2012; Lee et al., 2005] or corona radiata [Alexander
et al., 2009], or overlap of the lesion with the whole extent
of the CST [Jayaram et al., 2012]. However, walking and
gait entail considerably more complex functions than just
will-guided leg strength, and consequently are expected to
involve more extensive systems than solely the CST [Per-
ennou and Hillier, 2014]. Accordingly, neither Jayaram
et al. [2012] nor Dawes et al. [2008] found a significant
relationship between lesion CST overlap and walking
speed in the chronic stage post-stroke. In one study, the
amount of CST damage predicted ambulation outcome
assessed with the functional ambulation category (FAC)
scale [Kim et al., 2013], possibly suggesting a differential
role of CST damage on walking speed versus actual ambu-
lation. Interestingly, Alexander et al. [2009] found that
damage to the putamen, insula and external capsule was
related to gait asymmetry, while abnormal activation of
the basal ganglia, insula, secondary somatosensory area, or
supplementary motor and premotor cortex during leg
movement have also been found associated with impaired
lower limb movement [Dobkin et al., 2004; Enzinger et al.,
2009; Mihara et al., 2012; Miyai et al., 2003]. Overall, there-
fore, other structures beyond the CST may be involved in
walking impairment after stroke.
Although as just described, there is relatively abundant
knowledge regarding the lesion anatomy of post-stroke
motor impairment, particularly for the upper limb, much
less is known of the predictive value of lesion topography
for response to therapy, that is, the change in clinical meas-
ures of motor deficit following participation in character-
ized rehabilitation intervention. Several studies have
consistently reported that CST damage predicts response
of upper limb motor deficit to therapy [Lindenberg et al.,
2012; Nouri and Cramer, 2011; Riley et al., 2011; Stinear
et al., 2007]. In those studies, however, a substantial frac-
tion of the variance in response to therapy remained unex-
plained, suggesting other systems are also involved. So
far, two studies only have addressed the predictive value
of CST damage for walking recovery. Both showed no sig-
nificant relationship of CST lesion overlap [Burke et al.,
2014; Dawes et al., 2008], further suggesting that CST is
not a strong determinant of recovery of walking speed
and that other structures are probably involved.
In the present prospective study on a substantial sample
of stroke survivors, we used volumetric CST lesion load
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measurement [Zhu et al., 2010] to assess the relationship
between CST damage and response of walking speed to
ambulation rehabilitation. In addition to specific CST dam-
age volumetry, we also used voxel-based lesion–symptom
mapping (VLSM) [Bates et al., 2003] to assess the role of
non-CST structures. Finally, in addition to walk speed,
two clinical scales measuring everyday mobility were also
obtained.
SUBJECTS AND METHODS
Patients
Participants were prospectively recruited in the Soft-
Scotch Walking Initial FooT (SWIFT) Cast randomized con-
trolled trial. The trial evaluated the efficacy of augmenting
conventional therapy, which could include standard ankle–
foot orthoses, with a specific ankle–foot cast (SWIFT Cast) to
enhance walking recovery [Pomeroy et al., 2012]. Only those
patients who had agreed to undertake magnetic resonance
imaging (MRI), which was optional per protocol, were eligi-
ble for this study. As the trial was completely neutral [Pom-
eroy et al., in press], both patient groups were merged for
the analysis, as done in two previous publications [Burke
et al., 2014; Cramer et al., 2007].
As detailed elsewhere [Pomeroy et al., 2012], inclusion
criteria were: aged more than 18 years; 3–42 days after
stroke; infarct or haemorrhage; subjects in whom gait reha-
bilitation was judged both necessary and potentially use-
ful, namely presence of gait abnormalities (knee
hyperextension and/or abnormal initial floor contact) but
able to take at least three steps while supported by two
people; no contractures at hip, knee, ankle, or forefoot or
loss of skin integrity over the paretic foot/lower limb; able
to follow a 1-stage command, that is, sufficient communi-
cation/orientation for interventions in this trial; and other-
wise, physically fit for rehabilitation. Potentially eligible
patients were enrolled into the study as soon as they were
able to take at least three steps while supported by two
people. Nature of the stroke (i.e., ischemic or haemor-
rhagic) and ischemic stroke sub-type (i.e., large-vessel or
lacunar) and topography were not part of the inclusion cri-
teria as the aim of this study was to recruit a sample as
representative of patients referred for gait therapy to a
rehabilitation unit as possible.
The protocol was approved by the relevant Regional
Ethics Committees and registered on a clinical trials data-
base (ISRCTN 39201286). Each participant gave signed
informed consent.
Clinical Assessment
Functional performance measures were taken at entry
into the study and the end of 6 weeks of intervention
phase [Pomeroy et al., 2012]. The primary outcome mea-
sure was average walking speed (m/s). Walking speed
was measured using a 2-D light switch and video system
which has good reliability [Ugbolue et al., 2013]. Walking
speed was chosen as the primary measure for the investi-
gation of clinical efficacy as it (a) has international clinical
utility; (b) was the target functional improvement for a
SWIFT Cast; (c) is a meaningful functional outcome for
stroke survivors; and (d) is used widely in stroke rehabili-
tation trials.
In addition to walk speed, which is an objective metric
for walking ability, two functional mobility scales that
incorporate other factors than just motricity were obtained
as secondary outcomes, namely the FAC and the modified
rivermead mobility index (MRMI) [Lennon and Johnson,
2000]. The FAC scale has six levels [Holden et al., 1984]
ranging from unable to walk (score 0) to able to walk inde-
pendently (score 5), and includes components of balance
and supporting use of the upper limbs for the scores up to
4. This measure has been found to have strong inter-rater
and test–retest reliability [Mehrholz et al., 2007]. The
MRMI measures functional mobility across eight tasks
including turning over in bed, sitting up from the lying
position, sitting balance, transferring to a chair, sitting to
standing, walking indoors and ascending stairs [Walsh
et al., 2010]. Each MRMI task ranges from “unable to per-
form” (score 0) to “independent” (score 5). The amount
and content of the physical therapy received by partici-
pants is described elsewhere [Pomeroy et al., in press].
The mean number of trial-specific rehabilitation sessions
per participant was nine, with each session lasting a mean
of 40 (SD 16) min over the 6-week intervention phase.
Given the aim of this study to assess the anatomical pre-
dictors of response to therapy, the difference between the
baseline and outcome measures for the three behavioural
variables detailed above were calculated and used in all
statistical analyses below, unless indicated otherwise.
MRI Data Acquisition
The imaging sub-study was part of the prospective trial
design [Pomeroy et al., 2012], and aimed to address the
question Does stroke location predict response to gait reha-
bilitation?, “predict” being used here in the statistical per-
spective, not at the individual subject level, that is, is there a
location that correlates with response to therapy across the
group? Patients who agreed to undergo scanning under-
went structural MRI including a whole-brain “volume”
MPRAGE T1-weighted sequence and a T2-weighted FLAIR
sequence (see below). To have an accurate delineation of the
cerebral lesion, this session was undertaken 3–8 weeks after
stroke onset so that the lesion had stabilized [Gaudinski
et al., 2008], that is, without remaining swelling from
oedema but before substantial shrinkage develops [Deoni
et al., 2008; Gale and Pearson, 2012].
Scanning was performed at two recruiting centres using
similar Siemens 1.5T scanners (Avanto and Magnetom
Sonata, respectively). Whole-brain T1-weighted MRI scans
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were acquired using a standard magnetization-prepared
rapid acquisition gradient-echo (MPRAGE) sequence,
which was followed by a standard whole-brain T2-
weighted fluid-attenuated inversion recovery (FLAIR)
sequence with 4-mm thick slices and 1-mm interslice gap.
Lesion Delineation
Using MRIcron (www.cabiatl.com/mricro/index.html),
the stroke lesion was delineated on FLAIR images (with
help from the T1-MPRAGE images whenever appropriate)
by a stroke neurologist with imaging experience (J-CB),
blinded to all clinical data except the side of the stroke. In
addition, white matter hyperintense lesions on FLAIR
were rated according to the standard Fazekas scale, from 0
(absent) to 3 (maximum) [Fazekas, 1989].
Image Processing
All image processing was performed in SPM8 (Well-
come Trust Centre for Neuroimaging, http://www.fil.ion.
ucl.ac.uk/spm/software/spm8). The FLAIR images were
Figure 1.
Lesion overlap map from the 50 participants overlaid on a standard
MNI space brain after the right-sided lesions had been flipped to
the left side (see Methods section), and projected onto the whole
set of axial slices from the canonical normal subject T1-weighted
MRI in Montreal Neurological Institute (MNI) space. The number
of participants in each pixel is shown on the pseudo-colour scale
on the right. The maximum number of participants with a lesion
for any voxel was 24 (red colour) and involved the striato-capsular
area and corona radiata. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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coregistered to the T1 images and the T1 images were
resliced to the FLAIR space. The lesions were smoothed
using the SPM masking option of MRIcron [Rorden et al.,
2007] (http://www.cabiatl.com/mricro/mricro/mricro.
html). T1 images were transformed into Montreal Neuro-
logical Institute (MNI) space using the unified Segmenta-
tion and Warping process with lesion cost function
masking [Andersen et al., 2010; Brett et al., 2001] and the
transformation parameters were applied to the original
lesions using nearest-neighbour interpolation to place the
lesions in standard space.
For the analyses described below, all right-sided lesions
were flipped onto the left hemisphere to permit compari-
son across the whole group.
CST Lesion Load
The aim of this analysis was to assess the relationship
between the amount of damage to the CST and the clinical
measures across the patient sample. For each subject, the
probabilistic volume overlap of their lesion with the CST
was computed according to the weighted-CST lesion load
(wCST-LL) method [Zhu et al., 2010]. The wCST-LL was
calculated by weighing each slice of overlap with the CST
by the ratio of the maximum cross-sectional area of the
CST over the cross-sectional area of that specific slice. This
weighing option corrects for the narrowing of the CST
descending into the PLIC from the motor cortex. In con-
trast to Zhu et al [2010], the canonical CST tract used in
this study was determined by a probabilistic fibre tracking
approach using FSL 3.1.2 (http://www.fmrib.ox.ac.uk)
and DTI data from 12 healthy elderly control subjects (9
male; mean age: 56.56 14.8 years) [Feng et al., in press].
Pre-processing steps included correction for eddy current
effects, skull stripping as well as estimation and fitting of
diffusion parameters. Single slice regions of interest (ROIs)
were drawn on the FA images in the pons, PLIC and the
white matter underlying the posterior part of the precen-
tral gyrus. Exclusion ROIs were drawn on the superior
and medial cerebellar peduncle to exclude fibres to the
cerebellum, as well as the middle sagittal region covering
the brain stem and corpus callosum to exclude trans-
hemispheric fibres. Probtrackx (http://www.fmrib.ox.ac.
uk/fsl/fdt/fdt_probtrackx.html) was used to track fibres
from the pons ROI as the seeding region. Tracts were nor-
malized to the SPM5 T2 template implemented in MAT-
LAB (The Mathworks, Natick, MA), which was achieved
by normalizing the DWI image to the SPM 5 T2 template,
and then applying the normalization parameter to each
CST tract. A 50th fractional anisotropy percentile threshold
was applied to each CST fibre, and then the 12 tracts were
each binarized and summed to create the canonical CST.
wCST-LL values obtained using this canonical CST signifi-
cantly (P< 0.0001) predicted 3-month Fugl-Meyer (FM)
[Fugl-Meyer et al., 1975] upper extremity sensorimotor
outcome in an unrelated dataset of 76 subjects [Feng et al.,
in press]. Supporting Information, Figure 1 illustrates the
excellent coverage of motor fibres originating from the M1
leg area.
VLSM
VLSM was performed using vlsm2 version 2.53 [Bates
et al., 2003] (http://www.neuroling.arizona.edu/resources.
html). Each VLSM analysis identified clusters of voxels
with statistically significant t-values comparing voxelwise
subjects’ clinical measures with lesions to those without
lesions, and identified a peak t-value within each signifi-
cant cluster. Note that to avoid spurious results due to
low numbers of lesioned voxels, only voxels lesioned in at
least six participants were tested. The VLSM analysis
involved first creating a t-value map showing voxels with
greatest difference in responses to lesioned and unlesioned
status, thresholded at an uncorrected default cut-off of
P< 0.005. To correct for multiple comparisons the signifi-
cance of the cluster was then assessed by randomly per-
muting the measures 5000 times between subjects, that is,
nonparametrically. Only clusters with a peak t-values in
the top 5% of those generated randomly were considered
significant (P< 0.05, permutation corrected).
To determine as objectively as possible the anatomical
structures involved by the significant clusters, the location
of each cluster was labelled according to the Hammers
atlas [Hammers et al., 2003; Heckemann et al., 2006]
(www.brain-development.org) for grey matter structures,
the John Hopkins University (JHU) white matter tracts
atlas [Hua et al., 2008], and where possible the Anatomy
[Eickhoff et al., 2005] atlas for Brodmann’s areas (BAs).
We used the JHU tract atlas to assess the overlap of VLSM
clusters with white matter tracts, including the CST. For
each label, the percentage of the cluster overlapping with
the given structure/tract/BA was obtained and tabulated.
Statistical Analysis
Clinical data
Descriptive statistics were used to present the clinical
data and their inter-relationships. Continuous measures
were summarized by mean and standard deviation or 95%
TABLE I. Baseline characteristics of the subjects
(N550) showing median (interquartile range) and range
unless otherwise stated
Male/female 28/22
Left/right 25/25
Infarct/haemorrhage 41/9
Age (years) 64.6 (15.0)a, 27–100
Time to baseline assessment (days) 16.0 (9–25), 3–42
Fazekas score 2 (1–2), 0–3
Lesion volume (cm3) 4.4 (0.8–28.1), 0.05–188.18
aMean (SD).
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confidence interval, and categorical data by median with
interquartile range. Correlations were made using Ken-
dall’s Tau; corrections for multiple tests were deemed
unnecessary given the descriptive aim. Statistical analyses
were performed in SPSS 21 (IBM SPSS Statistics for Win-
dows, Version 21.0. Armonk, NY: IBM Corp). Because a
relatively large sample was used in this study, interpreta-
tion of the findings from correlations was not based only
on the P value, which indicates the presence of a statisti-
cally significant relationship, but also on the r value,
which assesses the strength of the relationship. In this
study, we considered tau 0.6 to represent a strong
relationship.
wCST-LL analysis
The analysis of the relationship between wCST_LL and
response to therapy for each of the three clinical scales was
carried out with age, Fazekas score, time from stroke onset
to baseline performance measures (to be referred to as
“Time” below), and baseline score for the considered vari-
able as added nuisance covariates. Lesion volume was not
included as covariate as this can cause spurious results
given the relationship between stroke size and topography
according to vascular territories [Nachev, 2014]. In addition,
there was not even a trend of a correlation between lesion
volume and response to therapy for any of the three clinical
variables assessed (r range: 0.01–0.06, all P> 0.53; data not
shown). Multiple regressions were carried out for Walk
speed and MRMI which are continuous and multiple cate-
gories variables, respectively, while for FAC, which has
only five categories, ordinal regression was carried out.
VLSM
As with wCST-LL, all four covariates described above
were added in the VLSM analysis for each of the three
variables.
RESULTS
Patient Characteristics and Behavioural Scores
Of the 105 trial participants, 56 consented to MRI but
four were not suitable for inclusion in the image analysis
(one had a hemi-craniectomy and another had marked
hydrocephalus entailing marked brain distortion, one
declined study approval after the MR session, and one
had no visible lesion on MR), leaving 52 subjects with
adequate MRI for this study. Due to practical difficulties
in obtaining MRI slots for this research, some scans were
carried out slightly later than expected (mean time of MR
relative to stroke onset: 52 days; range 17–74 days), even
sometimes a few days after end of therapy. Because out-
come clinical scores were not available in two additional
patients, the final analysis was on 50 subjects.
Table I shows the patient demographics. The median
time from stroke to enrolment in the trial was 16 days
(range: 3–42 days). This subset of 50 subjects did not sig-
nificantly differ from the remaining 53 trial subjects in any
demographic or baseline clinical measure (data not
shown). This material was made of 41 ischemic and 9 hae-
morrhagic strokes, of which four were hemispheric, four
supratentorial deep-seated and one involved the brain-
stem. Of the ischemic strokes, 22 were MCA-territory
strokes (eight of which were purely deep-seated and two
TABLE II. Summary functional performance measure (median and interquartile range unless otherwise stated;
N5 50)
Baseline Outcome Change Effect size P valuea
Walk speed (m/s) 0.00 (0.00–0.25) 0.49 (0.18–0.71) 0.24 (0.00–0.51) 0.69 <0.000
MRMI 24 (19–32) 37 (34–38) 10 (4–15) 0.73 <0.000
FAC 1 (0–2) 4 (4–4) 3 (1–4) 0.58 <0.000
FAC5 Functional Ambulation Category; MRMI5Modified Rivermead Mobility Index.
Change means the difference between Outcome and Baseline, that is, response to therapy. Effect sizes are from Cohen’s r25Wilcoxon
Z
N. Small effect size (0.01–0.06); medium effect size (0.06–0.14); large effect size (>0.14).
aWilcoxon signed rank test.
TABLE III. Correlation of response to therapy for the three behavioural measures with
four baseline variables (Kendall’s Tau)
Age (years) Fazekas score Baseline score Time from stroke to baseline
Walk speed 20.19 (P5 0.06) 20.18 (P5 0.10) 20.21 (P5 0.07) 20.23 (P< 0.03)
FAC 20.25 (P< 0.02) 20.04 (P5 0.76) 20.60 (P< 0.001) 20.26 (P< 0.02)
MRMI 20.11 (P5 0.29) 0.01 (P5 0.91) 20.65 (P< 0.001) 20.26 (P< 0.01)
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associated with posterior cerebral artery infarction), two
were anterior cerebral artery (ACA) strokes, one was an
anterior choroidal artery stroke, and 16 were lacunar
infarcts (three of which located in the brainstem).
Table II shows the functional scores of the participants
at baseline and 6-week outcome, and the change from
baseline to outcome. There was significantly improved
performance following treatment in all three functional
measures.
There were significant positive correlations regarding
change in scores among all three clinical measures (all
P< 0.03), particularly between FAC and MRMI (P< 0.001).
However, they were weak between Walk speed and the
other two scales (highest tau value: 0.386), while the tau
value between MRMI and FAC was 0.611, indicating that
a large part of the variance remained unexplained.
Accordingly, the wCST-LL and VLSM analyses were con-
ducted for each variable separately, which also was justi-
fied by the marked differences in the everyday functions
they assess (see Discussion section).
Table III shows the correlations of response to therapy
for each behavioural measure with age, Fazekas score, time
and baseline score. Age significantly but weakly negatively
affected FAC score change. Baseline score was a strong pre-
dictor of response of FAC and MRMI scores, but not for
Walk speed. The negative correlations indicated that the
worse the initial score, the larger the absolute behavioural
gain from therapy. Finally, Time significantly predicted
score change for all three variables, again in the expected
negative direction, but the correlations were weak.
wCST Lesion Load Analysis
One of the lesions was in the medulla and outside the
standardised control CST, so this analysis was run on 49
subjects. Tables IV–VI show the results of the multiple
regressions testing the correlation between the three
response-to-therapy variables and wCST-LL adjusting for
age, Fazekas score, time and baseline score. Results from
the multiple regression analysis revealed that CST damage
did not significantly predict Walk speed change (P5 0.60),
but significantly impacted changes in both FAC and MRMI
(P5 0.030 and 0.024, respectively), albeit not strongly so,
all in the negative, that is, biologically expected direction.
Baseline score had a strong influence on FAC and MRMI,
but only a weak—albeit significant—influence on Walk
speed. Time modestly but significantly influenced FAC and
MRMI. Age significantly influenced FAC response only.
Interestingly, Walk speed was the least well-predicted vari-
able by the five covariates considered together.
VLSM
Figure 1 shows the lesion overlap map overlaid on a
standard MNI space brain, documenting that the most
common lesion site involved the striatocapsular area. Out
of the 50 subjects, four lesions had no overlap with any of
the other lesions and the maximum number of overlap-
ping lesions was 24. Supporting Information, Figure 2
shows the overlap for voxels lesioned in at least six sub-
jects, that is, the “search volume” for the VLSM analysis.
TABLE IV. Multiple regressions to predict Walk speed response to therapy (N5 49 subjects)a
b Standard Error Standardized b coefficients Partial r P Pearson r
wCST-LL 20.007 0.014 20.085 20.079 0.606 20.004
Age 20.002 0.003 20.108 20.100 0.512 20.247
Fazekas Score 20.060 0.050 20.193 20.180 0.236 20.262
Baseline score 20.376 0.185 20.274 20.296* 0.049 20.295
Time 20.006 0.004 20.249 20.250 0.098 20.327
*p<0.05.
aResponse to therapy as dependent variable from a multiple regression with predictors’ wCST load, age, Fazekas score, baseline Walk
Speed and Time. For each variable, the Beta, standard error for Beta and standardized Beta Coefficient is given together with the signifi-
cance for this component, the raw Pearson correlation of the dependant variable with response to therapy, and the partial correlation
independently of other variables.
TABLE V. Ordinal regression to predict FAC response
to therapya
OR 95% CI Wald v2(1) P value Pearson r
wCST-LL 0.80 0.66–0.98 4.71 0.030* 20.155
Age 0.94 0.89–0.98 6.78 0.009* 20.302*
Fazekas score 1.29 0.64–2.60 0.50 0.478 20.046
Baseline score 0.21 0.11–0.38 25.54 0.000** 20.658**
Time 0.94 0.89–1.00 4.37 0.037* 20.331*
aResponse to therapy as dependent variable from an ordinal regres-
sion with predictors’ wCST load, age, Fazekas score, baseline Walk
speed and time. For each variable, are given the odds ratio (OR),
95% confidence interval for the OR, the v2 together with its signifi-
cance for this component, and the raw Pearson correlation of the
dependant variable with response to therapy.
*Significant P< 0.05.
**P< 0.001. The OR for Age implies the odds of recovery decrease
by 0.94 for each increase in age of 1 year. Units for Time to Base-
line are days, and for wCST cm3.
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This illustrates that the striatocapsular area, the frontal
white matter up to the centrum semiovale, the external
capsule, the insular cortex and extensive cortical areas
including the precentral gyrus and the frontal opercula
were all encompassed in the search volume. A power map
from the lesion overlaps with the zero-thresholded left
CST overlaid from the John Hopkins University (JHU)
white matter tracts atlas is shown in Supporting Informa-
tion, Figure 3, illustrating that the CST intersects close to
the peak power area.
According to a design that included age, Fazekas scores,
time and baseline scores as nuisance covariates, the VLSM
analysis revealed a single significant cluster for Walk
speed response to therapy, with a P value< 0.02. Lesion in
this area was significantly correlated with poorer recovery.
Table VII labels the cluster’s centre of mass in MNI space,
together with the percentage of the cluster labelled accord-
ing to the Hammers and JHU white matter tracts atlases.
The overlaps with the Anatomy are not shown because
the cluster did not overlap with any Brodmann area iden-
tified in this atlas. Figure 2 depicts this cluster overlaid on
a standard MNI template. The areas encompassed
included the insula, lateral and anterior putamen and
external capsule, and the superior longitudinal, inferior
fronto-occipital and uncinate fasciculi. Of note, the cluster
did not overlap with the CST. There were no significant
findings with FAC or MRMI.
DISCUSSION
To our knowledge, this is the first study to combine CST
damage measurement and VLSM to comprehensively
assess the relationship between lesion topography and
clinical measures of motricity post-stroke. To this end, we
used the wCST-LL method [Feng et al., in press; Zhu
et al., 2010] and VLSM [Bates et al., 2003] to assess the role
of CST and non-CST damage, respectively. Because the
former assesses the CST in its entire intracranial length
rather than locally as the latter does, it is expected to have
much greater sensitivity and accuracy to assess the role of
CST lesion in behavioural outcome. Our specific goal
using this complementary approach was to investigate
whether lesion anatomy predicts the response of stroke-
induced impaired walking and mobility to rehabilitation.
Another strength of our study is the use of three different
outcome measures, namely walk speed as primary out-
come and FAC and MRMI, two functional scales assessing
distinct daily functions—namely getting out of bed and
ambulating and walking under various environments,
TABLE VI. Multiple regressions to predict MRMI response to therapy (same explanations as Table IV)
b Standard Error Standardized b coefficients Partial r P Pearson r
wCST-LL 20.489 0.209 20.241 20.335* 0.024 20.195
Age 20.079 0.049 20.168 20.241 0.111 20.125
Fazekas score 0.382 0.768 0.051 20.076 0.621 0.001
Baseline score 20.701 0.081 20.740 20.798** 0.000 20.752*
Time 20.133 0.058 20.215 20.330* 0.027 20.369*
Figure 2.
Significant VLSM cluster (yellow) showing lesioned voxels nega-
tively correlated with Walk Speed response to therapy, projected
onto the MNI canonical T1-weighted MRI (see Fig. 1 for details).
Only the axial slices with significant voxels are presented (the fig-
ure above each slice is the z coordinate in mm in MNI space).
Statistical significance was determined following permutation
correction at P< 0.05 FWE correction for multiple comparisons,
and controlling for age, Fazekas score, time since stroke onset and
baseline Walk speed score as nuisance covariates in the multivari-
ate model (see Methods section). See Table V for coordinates, P
value and anatomical location of the cluster. The canonical JHU
cortico-spinal tract (blue) did not overlap with the cluster. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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respectively—as secondary measures. A final strength is
the substantial sample size available, affording adequate
statistical power.
General Points
Before discussing the results, it is worth clarifying from
the outset that our aim was not to decipher the mecha-
nisms underlying recovery of walking after stroke, but to
determine if stroke lesion topography predicts response to
gait rehabilitation. We addressed the following pragmatic
clinical question: can response to gait therapy be predicted
based on stroke lesion topography as determined on
standard clinical MRI? Accordingly, we did not assess var-
iables such as functional activation patterns, functional
and structural connectivity changes, white matter tract
degeneration, or structural changes remote from the lesion
such as enlarged cortical thickness or white matter bun-
dles, that all can underlie plastic processes and hence con-
tribute, or impede, functional recovery [Calautti and
Baron, 2003; Cramer, 2008; Johansen-Berg et al., 2002;
Sharma et al., 2009]. Although these MRI-based investiga-
tions would be of interest to decipher the mechanisms
underlying recovery of walking post-stroke, they would
not contribute to our pragmatic clinical aim.
Three main results emerged from our study. First, base-
line scores and time to baseline assessment and less con-
sistently age, predicted response to therapy for some or all
clinical variables, confirming these are important covari-
ates to consider when assessing the independent predic-
tive value of lesion topography for behavioural gains.
Second, using a multiple regression model accounting for
the above covariates plus white matter lesion score, CST
damage independently influenced FAC and MRMI
response, but not Walk speed. Importantly, of the three
clinical measures, Walk speed response was the least well
predicted by the five-variable model, suggesting other var-
iables are operative. Accordingly, assessing non-CST lesion
involvement using VLSM revealed significant findings
only for Walk speed, namely a cluster involving the insula,
putamen, external capsule and surrounding white matter
tracts.
The findings regarding the covariates deserve a brief
comment. Baseline score had the strongest influence, con-
sistent with previous studies on post-stroke walking and
ambulation [Burke et al., 2014; Dawes et al., 2008; Jorgen-
sen et al., 1995; Kollen et al., 2005]. That time elapsed since
stroke onset also influenced response to therapy was
expected given that this study enrolled patients relatively
early after stroke, and that recovery slope is steeper at the
early post-stroke stage [Duncan et al., 1992]. Previous
studies carried out in the chronic stage also reported an
effect of time on recovery [Kollen et al., 2005; O’Shea
et al., 2014; Stinear et al., 2007]. Again consistent with pre-
vious work [Dobkin et al., 2014; Held et al., 2012; Jorgen-
sen et al., 1995; Lam et al., 2010; Stinear et al., 2007], age
impacted—albeit weakly so—recovery of ambulation.
Finally, white matter FLAIR hyperintense lesion load did
not significantly influence recovery, but was included a
priori in the model given its previously reported impact
[Held et al., 2012].
Involvement of the CST
CST damage independently, albeit weakly, predicted
FAC and MRMI response to therapy, but not Walk speed.
This limited impact of CST damage on gait and ambula-
tion recovery may seem unexpected given the reports
regarding the upper limb consistently showing a strong
effect [Lindenberg et al., 2012; Nouri and Cramer, 2011;
Riley et al., 2011; Stinear et al., 2007]. It is unlikely that our
findings are due to inadequate power, since the sample
size was similar to that analysed in a previous upper limb
impairment study also using wCST-LL [Zhu et al., 2010],
and several-fold larger than three positive studies of upper
limb response to therapy [Lindenberg et al., 2012; Riley
et al., 2011; Stinear et al., 2007] that all showed a strongly
significant role of the CST. Our findings are in fact entirely
TABLE VII. Significant cluster from the VLSM analysis of Walk speed response to therapy, obtained from a design
including age, Fazekas score, baseline Walk speed and time from stroke to baseline assessment as nuisance covari-
ates (see Methods section)
Cluster sizea Centre of massb P* Hammers (anatomy) JHU (white matter tracts)
Walk Speed 309 [230,5,4] <0.02 Insula (67) Putamen (27)
Middle frontal gyrus
(3)
Inferior fronto-occipital fas-
ciculus (28) Superior lon-
gitudinal fasciculus (24)
Uncinate fasciculus (14)
Anterior thalamic radia-
tion (3)
Clusters are anatomically labelled by the Hammers and John Hopkins University white matter label tracts (JHU) atlases (rounded % of
overlap in brackets). Only overlaps 1% are listed
aCluster size in voxels (corresponds to a volume of 2.47 mL).
bMNI coordinates.
*P value (P< 0.05 FWE following uncorrected threshold of P< 0.005; see Methods section).
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consistent with a previous study that reported that CST
damage predicted ambulation outcome assessed with FAC
[Kim et al., 2013], as well as with all previous reports that
assessed the role of CST damage in Walk speed outcome
[Jayaram et al., 2012] or response to therapy [Burke et al.,
2014; Dawes et al., 2008], which were all negative.
Previous work, also using the wCST-LL method, found
that within the same population of stroke survivors, CST
damage was more strongly related to upper limb than
lower limb sensorimotor function (assessed with the Fugl-
Meyer scale) (Schlaug et al., unpublished data). The
weaker predictive value of CST damage for lower com-
pared to upper extremity outcome might in part reflect the
fact that canonical CST templates do not include other
descending CSTs such as the cortico-rubral and the
cortico-tegmental spinal tracts, which have slight differen-
ces in their cortical origins compared to the pyramidal
tract [Ruber et al., 2012, 2013] and might innervate alpha
motoneurons on both sides of the spinal cord, either
directly or indirectly, as well as proximal muscles more
than distal muscles. As compared to upper extremity sen-
sorimotor function, walking involves quite different motor
control processes, including adapted body orientation rela-
tive to space and environment, trunk stabilization around
the body’s centre of mass, generation of alternate leg force
to produce a cycling movement, and secure navigation in
the surroundings [Perennou and Hillier, 2014], which
might account for a limited role of the CST, and an impor-
tant role for other structures, in this largely automatic
function. Conversely, that CST damage influenced FAC
and MRMI may reflect the more composite nature of these
scales that involve ‘cortical effort’, as they for instance
include on top of walking help with the upper limbs and
trunk mobility, and are assessed in real, complex environ-
ment such as bed surroundings or stairs.
Involvement of Other Structures
Given the lack of impact of CST damage on Walk speed
response, and the limited impact of the clinical variables
tested, the finding that a non-CST located cluster emerged
from VLSM is not unexpected. Based on VLSM, involve-
ment of the insula, lateral and anterior putamen and exter-
nal capsule hindered Walk speed response, independently
of the other covariates. Note that the percentages for lesion
overlap shown in Table V are only approximate because
the Hammer’s Atlas focuses on grey matter structures and
does not consider fine anatomical details. This is particu-
larly true for the “insula” label, which encompasses also
the external capsule, claustrum and extreme capsule, lead-
ing to gross overestimation of the overlap with the insula
proper. Note also that the VLSM cluster did not overlap
with the areas of highest statistical power (Supporting
Information, Fig. 3), which involve the deep white matter
and CST regions, and hence is not the result of intrinsic
bias. In addition, the permutation analysis was carried out
on the whole search area, not just on the voxels selected
by the initial first-level thresholding, that is, there was no
circularity or ‘double-dipping’ involved [Kriegeskorte
et al., 2009]. It is standard in VLSM studies to consider
correlations that survive this extremely stringent process
as very robust.
The putamen, as a node in the sub- cortico-cortical
motor loop, is involved in movement initiation, which is
impaired in Parkinson’s disease [Alexander et al., 1990;
DeLong and Wichmann, 2007], and in the implicit learning
and execution of well-learned sequences (i.e., procedural
memory) including walking and balance, accounting for
its apparent role in relearning to walk after stroke
[Scherder et al., 2011]. It is, therefore, not surprising that
damage to the putamen impairs the automatic act of walk-
ing. Previously, Alexander et al. [Fig. 2A; 2009] reported
an association of gait asymmetry and leg weakness to
lesions of the lateral putamen, external capsule and insula
in partly recovered stroke patients. Also, changes in puta-
minal fMRI activations during foot movement were found
to correlate well with improvements in walking speed fol-
lowing treadmill-based rehabilitation after stroke
[Enzinger et al., 2009]. Using VLSM, Wu et al. [2015]
recently reported that the putamen, insula and external
capsule, among other structures, contribute to poor post-
stroke functional outcome, and Cheng et al. [2014] found
that lesions to the insula affected global outcome. Overall,
therefore, our finding that damage to the putamen, insula
and external capsule affects recovery of walking seems
consistent with previous work.
The VLSM analysis also suggested that damage to the
superior longitudinal, inferior fronto-occipital and uncinate
fasciculi affected Walk speed response. The functions sus-
tained by the two former tracts are not well understood,
but they connect the prefrontal and premotor regions to the
occipital cortex, and as such could be involved in balance
and walking. Accordingly, white matter ischemic lesions
particularly involving the frontal lobe are associated with
gait impairment [de Laat et al., 2011]. More specifically,
damage to the superior longitudinal fasciculus has been
linked to decreased postural stability and wide-based gait
in elderly subjects [Scherder et al., 2011]. Regarding the
uncinate fasciculus, which connects the anterior part of the
frontal lobe to the medial and lateral temporal cortex, its
damage in aged people has been linked to decreased step
length and walking velocity as well as more generally with
apractic gait [Scherder et al., 2011]. Following a stroke,
damage to the superior longitudinal and uncinate fasciculi
were recently reported to contribute to worse global func-
tional outcome [Wu et al., 2015].
On a physiological standpoint, although the hard-wired
basis for synergistic stepping is engendered in the spinal
cord by so-called ‘central pattern generators’ (CPGs), walk-
ing involves a variety of supraspinal areas. Current under-
standing proposes that supraspinal control may in fact be
more important than CPGs for human walking [reviewed
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by Verma et al., 2012]. Evidence for this interpretation
includes the association of gait temporal asymmetry after
stroke with posterolateral putamen lesion [Alexander
et al., 2009]. More recently, it has also been shown that,
together with the pedunculopontine nucleus located in the
brainstem, the sub-thalamic nucleus, which is part of
Alexander’s motor loop referred to above and as such
strongly connected to the putamen and motor cortical
areas, plays a significant role in imagined gait in humans
[Lau et al., 2015].
Stroke Side
To ensure optimal statistical power, lesions were flipped
so that they all mapped onto the same hemisphere, as is
widely done [Cheng et al., 2014; Lo et al., 2010; Zhu et al.,
2010]. However, half of the patients had their stroke on
either side. Although there is only scant evidence that
ambulatory functions are hemisphere-dependent, this
hypothesis cannot be excluded. To address this, we
repeated post hoc, the VLSM analysis separately for the
left- and right-sided strokes (n5 25 in each), which
revealed no significant cluster for either (data not shown),
likely resulting from the loss of statistical power.
Mobility, Ambulation and Walk Speed
In this study, we used three different measures of recov-
ery, namely Walk speed as primary outcome, and FAC
and MRMI as secondary measures. Although response to
therapy for these three scales was significantly inter-
correlated, the correlations between Walk speed and the
other two scales were weak, while that between FAC and
MRMI was strong but accounted for only 50% of the var-
iance, in part, reflecting the fact that these two scales share
some items (e.g., walking independently). However, they
are constructed to assess different everyday functions, that
is, MRMI assesses the ability to move in and get out of
bed and walk, and includes items such as turning over in
bed, lying to sitting, sitting balance, sitting to standing,
standing balance, walking indoors and walking up the
stairs, while FAC assesses ambulation in various sur-
roundings including in parallel bars, evaluating the degree
of dependency on physical assistance right through to
independence. Accordingly, although their relationships
with wCST-LL and several co-variates are similar (Tables
V and VI), their relationship with age is different, and dif-
ferences between MRMI and FAC versus Walk speed
(Table IV) are even more striking. On a clinical point of
view, it would have no relevance to merge MRMI and
FAC into a single compound variable because they are
validated and used in whole in daily rehabilitation
practice, while Walk speed represents speed of walking in
a laboratory setting (i.e., walking forwards on a flat, even
floor, in a protected environment). These three scales were
prospectively chosen for this study for these specific rea-
sons. Likewise, it would not be clinically acceptable to
split these scales into their component items with a view
to derive independent dimensions, because they have been
prospectively constructed to represent a single overall
everyday function (e.g., getting out of bed and ambulate,
as at home) and then validated as a single value in exten-
sive investigations.
LIMITATIONS
Stroke topography varied widely across patients in our
sample (Supporting Information, Fig. 2), which could have
increased the variance and reduced the statistical strength
of this study despite the sizeable sample. However, our
sample was gathered prospectively among consecutive
referrals to rehabilitation centres, as part of a randomized
clinical trial. Accordingly, our sample is representative of
routine referrals for post-stroke gait rehabilitation, making
our results clinically relevant. Selecting post hoc a homo-
geneous sub-sample based on, for example, stroke topog-
raphy or etiology would have hindered this clinical
relevance and generalizability. Conversely, this variability
caused the VLSM search volume to be restricted to a cir-
cumscribed zone (Supporting Information, Fig. 2). Of note,
the M1 leg area, which is located on the medial surface of
the posterior frontal lobe and belongs to the ACA terri-
tory, was not part of the search volume, so the influence
of its lesion on treatment response could not be assessed.
However, consistent with the notion that ACA infarctions
are relatively rare, individual analysis of native space MRI
showed only two patients with leg area involvement, and
this was in fact associated in both cases with extensive
sub-cortical damage (Fig. 1).
Applying VLSM requires that a minimum number of
subjects with a lesion in any particular voxel be set a pri-
ori, simply because the statistical analysis is based on two-
sample comparisons and the ‘lesioned’ sample has to be
reasonably large to make robust inferences. Although there
is no strict recommendation on how to determine this
threshold in each particular study, we used six subjects in
this study because this is a statistically reasonable sample.
To further explore this issue, we carried out a post hoc
sensitivity analysis using 10 subjects as threshold. The
same cluster as with six subjects emerged, although as
expected smaller. We also carried out additional post hoc
sensitivity analyses using <0.001 as initial default P
threshold. Again the same cluster emerged, of smaller
extent but including the same anatomical structures. The
same was also true using a threshold of 10 subjects and
P< 0.001 as initial default. These sensitivity analyses
strongly support the robustness of our VLSM findings.
Regarding the topographical accuracy of VLSM, it has
been argued that studying patients with large-artery ische-
mic strokes might cause several-mm displacement of the
significant clusters because of the intrinsic vascular archi-
tecture affecting the shape of resulting infarcts [Mah et al.,
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2014]. In this situation, distinct approaches to image proc-
essing requiring very large datasets and simple, dichotom-
ized outcomes have been proposed [Mah et al., 2014].
However, our study enrolled patients with highly variable
stroke mechanisms (including 9 with haemorrhage) and
infarct locations and etiologies (including 17 with lacunar
infarcts), which would have mitigated any such effect.
Minor errors in the precise anatomical localisation of the
VLSM cluster cannot however be excluded.
We do not provide formal validation of our findings in
two independent samples. Given that the maximum num-
ber of patients with a lesion in any given voxel was 24
(Fig. 1), it was not feasible to split the sample in two to
assess reproducibility with adequate power. We have,
however, carried out an internal validation of the VLSM
cluster using the ‘leave-one-out’ approach, which showed
a stable peak location (centre of mass within 1.4 mm of
whole group cluster for 48/50 analyses). Nevertheless, rep-
licability of our findings is an important goal for future
studies. Finally, although we identify regions that may
help predict treatment response, we do not claim that we
can individually classify responders according to lesion
location. To be able to do this and for instance report sen-
sitivity and specificity, dichotomized classification of
response to therapy as responders and non-responders
would be required. However, there is no universally
accepted, validated dichotomized Walk speed, FAC or
MRMI response available at this time.
This study was carried out as part of a pragmatic rand-
omised trial assessing whether the benefits of routine
physical therapy could be augmented by an ankle–foot
orthosis (AFO), custom-made and fitted by a therapist
within a 24-h period, to provide optimal alignment of the
lower limb to the ground during walking [Pomeroy et al.,
2012]. Thus both groups received routine physical ther-
apy (treatment-as-usual) provided by the clinical physio-
therapists. As presented in detail elsewhere [Pomeroy
et al., in press], there were no statistically significant dif-
ferences between the two groups in the content of physi-
cal therapy they received, except that the control group
had higher use of off-the-shelf AFOs and the experimen-
tal group had as expected a higher use of a SWIFT Cast,
and there were no statistically significant differences
between the groups for any outcome measure, not even
evidence of trends (Pomeroy et al. submitted). The experi-
mental device, therefore, did not influence response to
therapy, and our findings are, therefore, applicable to
standard physical therapy in routine clinical practice.
In our study, there was a wide variance in the nominal
number of sessions given to and treatment duration
among patients [Pomeroy et al., in press], which could
have influenced response to therapy. However, this was a
pragmatic trial conducted in the routine rehabilitation
environment where participants were resident either a
hospital stroke rehabilitation ward or their own homes.
As is commonplace in similar trials, the study could not
make it compulsory for therapists to record in a system-
atic and standardized way each and every minute of rou-
tine therapy directed at enhancement of lower limb
function they gave to the participants of the trial. Thus,
the data collected is for therapy provided when a thera-
pist was present and does not include any additional,
self-administered therapy. Consequently, the data were
judged insufficiently accurate to be used as a covariate.
Nevertheless, applying standard methods for missing
data in the present MRI subset, we found no significant
relationship between treatment duration and response to
therapy for any of the three clinical measures (data not
shown). This is in fact not surprising as there is no clear
relationship between the amount of standard post-stroke
physiotherapy and clinical response [English and Veer-
beek, 2015], partly because more disabled subjects tend to
get more intensive therapy, whilst less affected subjects
are trained and instructed to recourse to self-
administered walking and balance exercises. Despite the
above caveats, we tested the effects of adding treatment
duration as a further covariate in the multivariate analy-
ses, which did not substantially change the results of the
wCST-LL analyses and VLSM.
In our study, the MRI was carried out only after recruit-
ment and start of therapy. This was considered unimpor-
tant for the assessment of the predictive value of stroke
lesion location for response to therapy because stroke
lesions are stable from about 2 weeks after onset (after
vasogenic oedema has vanished) up to around 12 weeks
(before significant shrinkage occurs) [Gaudinski et al.,
2008]. Because of difficulties in obtaining scanning slots
for this research study, some scans were carried out
slightly later than planned, which could have affected the
accuracy of lesion masks in some cases. In the event of
real-life application of our paradigm, however, MRI would
need to be carried out before the rehabilitation regimen is
decided, in order to guide it. In the clinical setting, if MRI
is not available other approaches to predict response of
walking speed to gait therapy could be considered such as
TMS [Hendricks et al., 2003a,b; Piron et al., 2005], which,
however, does not provide information regarding non-CST
located damage.
CONCLUSION
The findings from this study suggest that strokes affect-
ing the lateral putamen and neighbouring structures
reduce response of walking speed to standard rehabilita-
tion, while CST damage has statistically significant, though
somewhat limited, impact on two functional scales assess-
ing general mobility and gait.
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